Fundz

Paris-based Prelude raised €7.6 million in seed funding led by Singular and Seedcamp to expand its fraud-resistant SMS verification services across Europe and North America.

PUBLIC · PRLDNov 13, 2024

Amount Raised

€7.6 Million

Round Type

Seed

WilmingtonInformation TechnologyBiotechnologySustainabilitySoftwareHealth CarePrivacy And SecurityFintechBiotechnology Research

Investors

SeedcampSingular

Description

Prelude, a startup focused on fraud-resistant SMS verification solutions, has secured €7.6 million in seed funding. The investment, led by Singular and Seedcamp, will enable Prelude to enhance its platform and support its expansion plans.

Who else raised in Sustainability and Privacy And Security around the same time

Companies in the same sectors as Prelude that raised within 45 days of this round, from Fundz verified event records.

  • Electra Therapeutics raised $180M on December 18, 2024.
  • Ligence raised $3.2M (Seed) on November 13, 2024.
  • Medeloop raised $15M (Series A) on November 13, 2024.
  • Pharos raised $5M (Seed) on October 25, 2024.
  • Ikerian raised $8M (Series B) on October 16, 2024.
  • Shuttle Pharmaceutical Holdings raised $790K (Seed) on October 14, 2024.

Who to call at Prelude, and when

A new round usually means Prelude is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Prelude raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Prelude, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Prelude. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Prelude

Location

Wilmington, Delaware, United States

About

PreludeDx is a precision diagnostics company dedicated to providing actionable tools for managing early-stage breast cancer. Its first test, DCISionRT, is the result of over a decade of research focused on DCIS and was developed using technology licensed from the University of California, San Francisco. Designed to address the critical question faced by DCIS patients — What is my risk of recurrence, and what treatment is appropriate? — DCISionRT helps personalize treatment decisions with confidence.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Prelude raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsDan F., President and CEO hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Prelude's next move

See what Strategic adds

Prelude raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.